Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease

NCT04154826 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped non convincing results

Conditions

Mycobacterium Infections, Nontuberculous

Interventions

DRUG: Recombinant human interleukin-7

Sponsor

Revimmune

Collaborators

[object Object]